Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants
| Autor: | M E, Cvijic, K V, Chin |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Blotting
Western Cell Cycle Intracellular Signaling Peptides and Proteins Antineoplastic Agents CHO Cells Flow Cytometry Cyclic AMP-Dependent Protein Kinases KB Cells Drug Resistance Neoplasm Cricetinae Mutation Animals Humans ATP Binding Cassette Transporter Subfamily B Member 1 Carrier Proteins Protein Kinases |
| Zdroj: | Cell growthdifferentiation : the molecular biology journal of the American Association for Cancer Research. 8(12) |
| ISSN: | 1044-9523 |
| Popis: | Multidrug resistance (MDR) in cancer poses a major obstacle to the success of chemotherapy. We previously reported that cyclic AMP (cAMP)-resistant mutants of the Chinese hamster ovary and the mouse adrenal cortical carcinoma cells harboring defective regulatory (RI alpha) subunits of the cAMP-dependent protein kinase (PKA) are more sensitive than wild-type cells to chemotherapeutic agents that are substrates for P-glycoprotein. In addition, a transfectant overexpressing a mutant RI alpha cDNA showed similar increased sensitivity to these drugs. The altered drug sensitivity in the RI alpha mutants results from reduced expression of the mdr gene, suggesting that PKA may regulate its expression. In this study, we evaluated the sensitivity of several Chinese hamster ovary catalytic (C) subunit mutants to various anticancer drugs. Like the RI alpha subunit mutant, the C subunit mutants also exhibit decreased kinase activity and unresponsiveness to growth inhibition by cAMP. However, in contrast to the RI alpha subunit mutant, the C subunit mutants are not multidrug sensitive and maintain P-glycoprotein expression levels comparable to those of wild-type cells. Furthermore, the C subunit mutants display the same resistance patterns as wild-type cells to P-glycoprotein substrates, including Adriamycin, Taxol, and colchicine. No significant difference was observed in their sensitivity to non-MDR drugs, such as 5-fluorodeoxyuridine, between wild-type, RI alpha, and C subunit mutant cells. These results suggest that the increased multidrug sensitivity in the PKA mutant cells results from alteration of the RI alpha subunit and not the kinase activity, thus implying novel functions for the RI alpha subunit. Therefore, genetic alteration of the RI alpha subunit of PKA may modulate drug resistance in cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|